Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000876619 | SCV001019212 | benign | Anemia, nonspherocytic hemolytic, due to G6PD deficiency | 2024-01-22 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001573886 | SCV001471702 | uncertain significance | not provided | 2020-10-07 | criteria provided, single submitter | clinical testing | |
Dunham Lab, |
RCV000876619 | SCV002599304 | likely pathogenic | Anemia, nonspherocytic hemolytic, due to G6PD deficiency | 2022-08-12 | criteria provided, single submitter | curation | Variant found in unrelated hemizygotes with deficiency (PS4_M, PP4). Decreased activity in red blood cells (53%) (PS3). SIFT and structural bioinformatics predictions suggest deleterious effect on protein function (PP3). Below expected carrier frequency in gnomAD (PM2). Reported as benign by Invitae (BP6). Post_P 0.988 (odds of pathogenicity 729.3, Prior_P 0.1). |
Laboratory of Diagnostic Genome Analysis, |
RCV001573886 | SCV001800395 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001573886 | SCV001965496 | likely benign | not provided | no assertion criteria provided | clinical testing |